Print（PDF/150KB） Dec. 18, 2023 Corporate

Sumitomo Pharma Announces Personnel Change

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) today announced the following personnel change. 

Change in Personnel (effective January 1, 2024)

Drug Development (Division)

Position as of January 1, 2024	Current position	Name
Vice President, Head of Clinical Research	Senior Fellow, CNS Clinical Development	Kazuki Yabuuchi